• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    Novogen Limited (NVGN)

    -NasdaqCM
    3.15 Up 0.17(5.70%) 4:00PM EST
    Add to Portfolio
    Prev Close:2.98
    Open:2.95
    Bid:3.01 x 500
    Ask:3.26 x 400
    1y Target Est:N/A
    Beta:-1.52
    Next Earnings Date:N/A
    Day's Range:2.88 - 3.26
    52wk Range:1.51 - 5.97
    Volume:843,042
    Avg Vol (3m):1,101,070
    Market Cap:31.50M
    P/E (ttm):N/A
    EPS (ttm):-0.75
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback